Patent details

EP4054584 Title: METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR

Basic Information

Publication number:
EP4054584
PCT Application Number:
IB2020000912
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP208842690
PCT Publication Number:
WO2021090061
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
French Title of Invention:
PROCÉDÉS DE TRAITEMENT ET/OU DE PRÉVENTION D'ÉVÉNEMENTS CARDIOVASCULAIRES INDÉSIRABLES MAJEURS (MACE) AVEC UNE COMBINAISON D'UN INHIBITEUR DE BROMODOMAINE BET ET D'UN INHIBITEUR DU TRANSPORT DU GLUCOSE DÉPENDANT DU SODIUM 2
German Title of Invention:
VERFAHREN ZUR BEHANDLUNG UND/ODER PRÄVENTION VON SCHWERWIEGENDEN KARDIOVASKULÄREN EREIGNISSEN (MACE) MIT EINER KOMBINATION AUS EINEM BET-BROMDOMÄNENINHIBITOR UND EINEM NATRIUM-ABHÄNGIGEN GLUCOSETRANSPORT-2-INHIBITOR
SPC Number:

Dates

Filing date:
04/11/2020
Grant date:
09/07/2025
EP Publication Date:
14/09/2022
PCT Publication Date:
14/05/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/07/2025
EP B1 Publication Date:
09/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
04/11/2040
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/07/2025
 
 

Name:
Resverlogix Corp.
Address:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, Canada (CA)

Inventor

1

Name:
LEBIODA, Kenneth Eugene
Address:
Canada (CA)

2

Name:
KHAN, Aziz Naeem
Address:
Canada (CA)

3

Name:
HALLIDAY, Christopher Ross Armstrong
Address:
Canada (CA)

Priority

Priority Number:
201962930860 P
Priority Date:
05/11/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/517; A61P 9/00; C07D 239/91; A61K 31/70; A61K 31/7042; A61K 31/7048; A61K 45/06;

Publication

European Patent Bulletin

Issue number:
202528
Publication date:
09/07/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages